Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 11 (November)

1. Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.
   Int J Cancer, 119(12): 2974-9. [Abstract] [Full-text]
2. Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.
   Int J Cancer, 119(12): 2931-7. [Abstract] [Full-text]
3. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
   Int J Cancer, 119(12): 2832-9. [Abstract] [Full-text]
4. Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy.
   Biopolymers, 83(5): 556-69. [Abstract] [Full-text]
5. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
   N Engl J Med, 355(18): 1851-62. [Abstract] [Full-text]
6. Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.
   J Med Genet, 43(11): 856-62. [Abstract] [Full-text]
7. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
   Int J Cancer, 120(1): 181-8. [Abstract] [Full-text]
8. Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes.
   Genes Chromosomes Cancer, 46(1): 87-97. [Abstract] [Full-text]
9. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
   Appl Radiat Isot, 65(1): 70-8. [Abstract] [Full-text]
10. Combination of integrin siRNA and irradiation for breast cancer therapy.
    Biochem Biophys Res Commun, 351(3): 726-32. [Abstract] [Full-text]
11. Clinically occult cutaneous metastases.
    J Am Acad Dermatol, 55(6): 1044-7. [Abstract] [Full-text]
12. Trilostane in advanced breast cancer.
    Expert Opin Pharmacother, 7(17): 2413-9. [Abstract] [Full-text]
13. Multiple cutaneous metastases from male breast carcinoma.
    J Am Acad Dermatol, 55(6): 1101-2. [Abstract] [Full-text]
14. Increased breast cancer risk after radiotherapy for acne among women with skin cancer.
    J Am Acad Dermatol, 55(6): 981-9. [Abstract] [Full-text]
15. Can differences in breast cancer utilities explain disparities in breast cancer care?
    J Gen Intern Med, 21(12): 1253-60. [Abstract] [Full-text]
16. Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation.
    Biochem Biophys Res Commun, 351(4): 1024-30. [Abstract] [Full-text]
17. Computer-aided detection in digital mammography: comparison of craniocaudal, mediolateral oblique, and mediolateral views.
    Radiology, 241(3): 695-701. [Abstract] [Full-text]
18. Full-field digital mammography on LCD versus CRT monitors.
    AJR Am J Roentgenol, 187(6): 1492-8. [Abstract] [Full-text]
19. Prospective assessment of computer-aided detection in interpretation of screening mammography.
    AJR Am J Roentgenol, 187(6): 1483-91. [Abstract] [Full-text]
20. Testing the effect of computer-assisted detection on interpretive performance in screening mammography.
    AJR Am J Roentgenol, 187(6): 1475-82. [Abstract] [Full-text]
21. CAD in screening mammography.
    AJR Am J Roentgenol, 187(6): 1474. [Abstract] [Full-text]
22. Comparison of full-field digital mammography and screen-film mammography for detection and characterization of simulated small masses.
    AJR Am J Roentgenol, 187(6): W576-81. [Abstract] [Full-text]
23. Ductal carcinoma in situ: computer-aided detection in screening mammography.
    Radiology, 241(3): 689-94. [Abstract] [Full-text]
24. Phyllodes tumor of the breast: correlation between MR findings and histologic grade.
    Radiology, 241(3): 702-9. [Abstract] [Full-text]
25. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.
    Oncogene, 25(55): 7305-10. [Abstract] [Full-text]
26. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study.
    BMC Cancer, 6: 268. [Abstract] [Full-text]
27. Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis.
    Am J Public Health, 96(12): 2165-72. [Abstract] [Full-text]
28. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.
    Am J Public Health, 96(12): 2173-8. [Abstract] [Full-text]
29. The role of FDG-PET/CT in suspected recurrence of breast cancer.
    Cancer, 107(11): 2545-51. [Abstract] [Full-text]
30. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.
    Cancer, 107(11): 2552-8. [Abstract] [Full-text]
31. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.
    Cancer, 107(11): 2662-8. [Abstract] [Full-text]
32. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
    Cancer, 107(11): 2535-44. [Abstract] [Full-text]
33. Biological activity of rainbow trout Ea4-peptide of the pro-insulin-like growth factor (pro-IGF)-I on promoting attachment of breast cancer cells (MDA-MB-231) via alpha2- and beta1-integrin.
    J Cell Biochem, 99(6): 1524-35. [Abstract] [Full-text]
34. Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.
    Cancer Immunol Immunother, 56(2): 135-46. [Abstract] [Full-text]
35. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.
    Cancer Immunol Immunother, 56(2): 205-15. [Abstract] [Full-text]
36. A simple and innovative device to measure arm volume at home for patients with lymphedema after breast cancer.
    J Clin Oncol, 24(34): 5434-40. [Abstract] [Full-text]
37. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
    J Clin Oncol, 24(34): 5381-7. [Abstract] [Full-text]
38. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.
    J Clin Oncol, 24(34): 5373-80. [Abstract] [Full-text]
39. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.
    J Clin Oncol, 24(34): 5366-72. [Abstract] [Full-text]
40. Decreased risk of stroke among 10-year survivors of breast cancer.
    J Clin Oncol, 24(34): 5388-94. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.